CoChat

Can LDL cholesterol be too low? Possible risks of extremely low levels

Olsson, A. G., Angelin, B., Assmann, G., Binder, C. J., Björkhem, I., Cedazo‐Minguez, A., Cohen, J., von Eckardstein, A., Farinaro, E., Müller‐Wieland, D., Parhofer, K. G., Parini, P., Rosenson, R. S., Starup‐Linde, J., Tikkanen, M. J., Yvan‐Charvet, L. · 2017 · Journal of Internal Medicine
Cited by 100

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Following the continuous accumulation of evidence supporting the beneficial role of reducing low‐density lipoprotein cholesterol (LDL‐C) levels in the treatment and prevention of atherosclerotic cardiovascular disease and its complications, therapeutic possibilities now exist to lower LDL‐C to very low levels, similar to or even lower than those seen in newborns and nonhuman species. In addition to the important task of evaluating potential side effects of such treatments, the question arises whether extremely low LDL‐C levels per se may provoke adverse effects in humans. In this review, we summarize information from studies of human cellular and organ physiology, phenotypic characterization of rare genetic diseases of lipid metabolism, and experience from clinical trials. Specifically, we emphasize the importance of the robustness of the regulatory systems that maintain balanced fluxes and levels of cholesterol at both cellular and organismal levels. Even at extremely low LDL‐C levels, critical capacities of steroid hormone and bile acid production are preserved, and the presence of a cholesterol blood–brain barrier protects cells in the central nervous system. Apparent relationships sometimes reported between less pronounced low LDL‐C levels and disease states such as cancer, depression, infectious disease and others can generally be explained as secondary phenomena. Drug‐related side effects including an increased propensity for development of type 2 diabetes occur during statin treatment, whilst further evaluation of more potent LDL‐lowering treatments such as PCSK 9 inhibitors is needed. Experience from the recently reported and ongoing large event‐driven trials are of great interest, and further evaluation including careful analysis of cognitive functions will be important.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12614

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 100

Metadata

Authors
Olsson, A. G., Angelin, B., Assmann, G., Binder, C. J., Björkhem, I., Cedazo‐Minguez, A., Cohen, J., von Eckardstein, A., Farinaro, E., Müller‐Wieland, D., Parhofer, K. G., Parini, P., Rosenson, R. S., Starup‐Linde, J., Tikkanen, M. J., & Yvan‐Charvet, L.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2017-05-18
Volume
281
Issue
6
Pages
534-553
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2600576046
Cited by
100
References
32
FWCI
10.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.